Journal of International Oncology››2017,Vol. 44››Issue (8): 604-607.doi:10.3760/cma.j.issn.1673-422X.2017.08.012

Previous ArticlesNext Articles

Analysis of intratumor heterogeneity in breast cancer precision medicine

Yi Zongbi, Ma Fei

  1. Department of Medical Oncology, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Online:2017-08-08Published:2017-07-21
  • Contact:Ma Fei, Email: drmafei@126.com E-mail:drmafei@126.com
  • Supported by:

    Science and Technology Planning Project of Beijing of China (D161100000816004)

Abstract:As a breakthrough of precision medicine, intratumor heterogeneity is a research hotspot and is correlated to tumorigenesis, metastasis and resistance to therapies. In breast cancer, evidence of intratumor heterogeneity has been documented by numerous studies and it is the main obstacle to find ideal tumor markers and personalized medicine. Further analysis including the feature and generation mechanism of intratumor heterogeneity and the methods to assessment intratumor heterogeneity in the clinic are the key to cancer precision medicine.

Key words:Breast neoplasms,Intra-tumor heterogeneity,Precision medicine